OS Therapies

NYSE: OSTX · Real-Time Price · USD
2.06
-0.09 (-4.19%)
At close: Aug 15, 2025, 3:59 PM
2.07
0.24%
After-hours: Aug 15, 2025, 07:31 PM EDT

OS Therapies Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-6.81B -4.34M -4.45M -4.84M
Interest Income
n/a 2.00 n/a n/a
Pretax Income
-8.88B -7.79M -6.25M -7.42M
Net Income
-8.88B -7.79M -6.25M -7.42M
Selling & General & Admin
3.97B 1.12M 1.15M 1.5M
Research & Development
2.84B 3.22M 3.29M 2.17M
Other Expenses
n/a 5.15K 1.21K 1.16M
Operating Expenses
6.81M 4.34M 4.45M 4.84M
Interest Expense
n/a 3.45M 1.81M 2.58M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-6.81M 4.34M 4.45M 4.84M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
20.87M 20.05M 23.1M 23.1M
Shares Outstanding (Diluted)
20.87M 20.05M 23.1M 23.1M
EPS (Basic)
-71.77 -0.39 -0.28 -0.33
EPS (Diluted)
-71.77 -0.39 -0.28 -0.33
EBITDA
-6.81B -4.34M -4.45M -4.84M
EBIT
-10.93B -4.34M -4.45M -4.84M
Depreciation & Amortization
2.78K 4.22K 805.00 805.00